CD40 ligation decreases its protein half-life at the cell surface

European Journal of Immunology

Volumn 38, Issue 3, 2008, Pages 864-869

  Tucker, Torry A ^a,b   Schwiebert, Lisa M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

CD40; Epithelial cell; TRAF molecules

Indexed keywords

CD40 LIGAND; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; CD40 ANTIGEN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR;

ANTIBODY COMBINING SITE; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; CELL LINE; CELL SURFACE; CONTROLLED STUDY; ENZYME METABOLISM; EPITHELIUM CELL; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN METABOLISM; AMINO ACID SUBSTITUTION; ANTIGEN ANTIBODY REACTION; BIOTINYLATION; CELL STRAIN HT29; CYTOLOGY; GENE DELETION; GENETIC TRANSFECTION; GENETICS; HALF LIFE TIME; IMMUNOLOGY; METABOLISM;

AMINO ACID SUBSTITUTION; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, CD40; BINDING SITES; BIOTINYLATION; CELL LINE; EPITHELIAL CELLS; HALF-LIFE; HT29 CELLS; HUMANS; SEQUENCE DELETION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TRANSFECTION; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS;

EID: 43649104357     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737828     Document Type: Article

References (37)

1. Cagnoni, F., Oddera, S., Giron-Michel, J., Riccio, A., Olsson, S., Dellacasa, P., Melioli, G. et al., CD40 on adult human airway epithelial cells: Expression and proinflammatory effects. J. Immunol. 2004. 172: 3205-3214.
2. Propst, S. M., Estell, K. and Schwiebert, L. M., Proinflammatory and Th2-derived cytokines modulate CD40-mediated expression of inflammatory mediators in airway epithelia: Implications for the role of epithelial CD40 in airway inflammation. J. Immunol. 2000. 165: 2214-2221.
3. Vonderheide, R., Prospect of targeting the CD40 pathway for cancer therapy. Clin. Cancer Res. 2006. 13: 1083-1088.
4. Eliopoulos, A. and Young, L., The role of the CD40 pathway in the pathogenesis and treatment of cancer. Curr. Opin. Pharmacol. 2004. 4: 360-367.
5. Jabara, H. H., Buckley, R. H., Roberts, J. L., Lefrance, G., Loiselet, J., Khalil, G. and Geha, R. S., Role of JAK3 in CD40-mediated signaling. Blood 1998. 92: 2435-2440.
6. Pullen, S. S., Dang, T., Crute, J. J. and Kehry, M. R., CD40 signaling through tumor necrosis factor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs. J. Biol. Chem. 1999. 274: 14246-14254.
7. Pullen, S. S., Miller, H. G., Everdeen, D. S., Dang, T. T. A., Crute, J. J. and Kehry, M. R., CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: Regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. Biochemistry 1998. 37: 11836-11845.
8. Pullen, S., Labadia, M., Ingraham, R., Medzhitov, R., Everdeen, D., Alber, T., Crute, J. and Kehry, M., High affinity interactions of tumor necrosis factor receptor-associated factors (TRAFS) and CD40 require TRAF trimerization and CD40 multimerization. Biochemistry 1999. 38: 10168-10177.
9. Reyes-Moreno, C., Girouard, J., Lapointe, R., Darveau, A. and Mourad, W., CD40/CD40 homodimers are required for CD40-induced phosphatidy-linositol 3-kinase-dependent expression of B7.2 by human B lymphocytes. J. Biol. Chem. 2004. 279: 7799-7806.
10. Grassme, H., Bock, J., Kun, J. and Gulbins, E., Clustering of CD40 ligand is required to forma functional contact with CD40. J. Biol. Chem. 2002. 277: 30289-30299.
11. Brown, K., Hostager, B. S. and Bishop, G. A., Regulation of TRAF2 signaling by self-induced degradation. J. Biol. Chem. 2002. 277: 19433-19438.
12. Hostager, B., Catlett, I. and Bishop, G., Recruitment of CD40 and tumor necrosis factor receptor associated factors 2 and 3 to membrane microdomains during CD40 signaling. J. Biol. Chem. 2000. 275: 15392-15398.
13. Jalukar, S. V., Hostager, B. S. and Bishop, G. A., Characterization of the roles of TRAF6 in CD40-mediated B lymphocyte effector functions. J. Immunol. 2000. 164: 623-630.
14. Moore, C. and Bishop, G., Differential regulation of CD40-mediated TNF receptor-associated factor degradation in B lymphocytes. J. Immunol. 2005. 175: 3780-3789.
15. Manning, E., Pullen, S., Souza, D., Kehry, M. and Noelle, R., Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent. Eur. J. Immunol. 2002. 32: 39-49.
16. Propst, S. M., Estell, K. and Schwiebert, L. M., CD40-mediated activation of NF-kB in airway epithelial cells. J. Biol. Chem. 2002. 277: 37054-37063.
17. Bishop, G. A., Moore, C. R, Xie, P., Stunz, L. L. and Kraus, Z. J., TRAF proteins in CD40 signaling. Adv. Exp. Med. Biol. 2007. 597: 131-151.
18. Higuchi, M. and Aggarwal, B., TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J. Immunol. 1994. 152: 3550-3558.
19. Watanabe, N., Kuriyama, H., Sone, H., Neda, H., Yamauchi, N., Maeda, M. and Nitsu, Y., Continuous internalization of tumor necrosis factor receptors in a human myosarcoma cell line. J. Biol. Chem. 1988. 263: 10262-10266.
20. Lee, K., Feig, C., Tchikov, V., Schnickel, R., Hallas, C., Schutze, S., Peter, M. and Chan, A., The role of receptor internalization in CD95 signaling. EMBO J. 2006. 25: 1009-1023.
21. Gavi, S., Yin, D., Shumay, E., Wang, H. and Malbon, C., Insulin-like growth factor-I provokes functional antagonism and internalization of β1-adrenergic receptors. Endocrinology 2007. 148: 2653-2662.
22. Hunker, C. M., Giambini, H., Galvis, A., Hall, J., Kruk, I., Veisaga, M. L. and Barbieri, M. A., Rin1 regulates insulin receptor signal transduction pathways. Exp. Cell Res. 2006. 312: 1106-1118.
23. Shenoy, S., Barak, L., Xiao, K., Ahn, S., Berthouze, M., Shukla, A., Luttrell, L. and Lefkowitz, R., Ubiquitination of β-arrestin links seven-transmembrane receptor endocytosis and ERK activation. J. Biol. Chem. 2007. 282: 29549-29562.
24. Winograd-Katz, S. E. and Levitzki, A., Cisplatin induces PKB/Akt activation and p38MAPK phosphorylation of the EGF receptor. Oncogene 2006. 25: 7381-7390.
25. Zhaung, G., Hunter, S., Hwang, Y. and Chen, J., Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-kinase-dependent Rac1 activation. J. Biol. Chem. 2007. 282: 2683-2694.
26. Frey, M. R., Dise, R. S., Edelblum, K. L. and Polk, D. B., p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration. EMBO J. 2006. 25: 5683-5692.
27. Geisler, C., TCR trafficking in resting and stimulated T cells. Crit. Rev. Immunol. 2004. 24: 67-86.
28. Rotin, D., Staub, O. and Haguenauer-Tsapis, R., Ubitination and endocytosis of plasma membrane proteins: Role of Nedd4/Rsp5p family of ubiquitin-protein ligases. J. Membrane Biol. 2000. 176: 1-17.
29. Funakoshi, S., Long, D., Beckwith, M., Conley, D., Tsarfaty, G., Tsarfaty, I., Armitage, R. et al., Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood 1994. 83: 2787-2794.
30. Eliopoulos, A. G., Davies, C, Knox, P, Gallagher, N. J., Afford, S., Adams, D. and Young, L. S., CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily. Mol. Cell Biol. 2000. 20: 5503-5515.
31. Vonderheide, R. H., Flaherty, K., Khalil, M., Stumacher, M., Bajor, D., Hutnick, N., Sullivan, P. et al., Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody. J. Clin. Oncol. 2007. 25: 876-883.
32. Gruenert, D. C., Basbaum, C. B., Welsh, M. J., Li, M., Finkbeiner, W. E. and Nadel, J. A., Characterization of human tracheal epithelial cells transformed by an origin-defective simian virus 40. Proc. Natl. Acad. Sci. USA 1988. 85: 5951-5955.
33. Noguchi, P., Wallace, R., Johnson, J., Earley, E. M., O'Brien, S., Pellegrino, M. A., Milstein, J. et al., Characterization of the WIDR: A human colon carcinoma cell line. In vitro 1979. 15: 401-408.
34. Tsukamoto, N., Kobayashi, N., Azuma, S., Yamamoto, T. and Inoue, J., Two differently regulated nuclear factor kB activation pathways triggered by the cytoplasmic tail of CD40. Proc. Natl. Acad. Sci. USA 1999. 96: 1234-1239.
35. Volz, B., Orberger, G., Porwoll, S., Hauri, H. P. and Tauber, R., Selective reentry of recycling cell surface glycoproteins to the biosynthetic pathway in human hepatocarcinoma HepG2 cells. J. Cell Biochem. 1995. 277: 537-551.
36. Varga, K., Jurkuvenaite, A., Wakefield, J., Jong, J. S., Guimbellot, J., Venglarik, C., Niraj, A. et al., Efficient intracellular processing of the endogenous cystic fibrosis transmembrane conductance regulator in epithelial cell lines. J. Biol. Chem. 2004. 279: 22578-22584.
37. Peter, K., Varga, K., Bebok, Z., McNicholas-Bevensee, C., Schwiebert, L., Sorscher, E., Schwiebert, E. and Collawn, J., Ablation of internalization signals in the carboxy-terminal tail of the cystic fibrosis transmembrane conductance regulator enhances cell surface expression. J. Biol. Chem. 2002. 277: 49952-49957.